Lv5
850 积分 2023-10-09 加入
Definitions in Hemophilia: Resolved and Unresolved Issues
11小时前
待确认
An update on the ‘danger theory’ in inhibitor development in hemophilia A
23天前
已完结
Risk factors for inhibitor development in hemophilia A
23天前
已关闭
Genetic Risk Factors and Inhibitor Development in Hemophilia: What Is Known and Searching for the Unknown
23天前
已完结
Population Pharmacokinetic Analysis of Recombinant Factor VIII Fc Fusion Protein in Subjects With Severe Hemophilia A: Expanded to Include Pediatric Subjects
24天前
已完结
Recombinant factor VIII Fc fusion protein: extended‐interval dosing maintains low bleeding rates and correlates with von Willebrand factor levels
24天前
已完结
Definitions in hemophilia: communication from the SSC of the ISTH
1个月前
已完结
International Society on Thrombosis and Haemostasis Clinical Practice Guideline for Treatment of Congenital Haemophilia—A Critical Appraisal
1个月前
已完结
International Society on Thrombosis and Haemostasis clinical practice guideline for treatment of congenital hemophilia A and B based on the Grading of Recommendations Assessment, Development, and Evaluation methodology
1个月前
已完结
Clinical evaluation of glycoPEGylated recombinant FVIII: Efficacy and safety in severe haemophilia A
1个月前
已完结
皖公网安备34019202002308
